Fig. 6

Docking results showing H-bonds and other interactions between protein-ligand complex of (a) ESR1-resveratrol, (b) ESR1-gallic acid, (c) ESR1-raloxifene core, (d) CYP19A1-letrozole, (e) CYP19A1-quercetin, (f) CYP19A1-piperine, (g) EGFR-Erlotinib, (h) EGFR-quercetin, (i) EGFR-gallic acid, (j) EGFR-resveratrol.